98%
921
2 minutes
20
Tandem SH2 domains occur in key protein mediators of phosphotyrosine signaling and have the capacity to drive high affinity interactions through the avidity that results with bisphosphorylated protein partners. However, challenges have prevented the broad exploration of tandem SH2 domain avidity and here we utilize advances in both computational modeling and experimental approaches to predict and test tandem SH2 domain recruitment. Theoretical model behavior suggests that maximum avidity occurs with closely spaced or flexibly linked phosphotyrosine sites, combined with moderate monovalent affinities - exactly around the affinities of SH2 domains with individual phosphotyrosine sites. Surprisingly, despite sequence diversity, structure-based analysis showed remarkably conserved three-dimensional spacing between SH2 domains across all tandem SH2 families, which we interrogate experimentally, suggesting evolutionary optimization for avidity interactions. The combination of structure-based analysis of domain spacing with available monovalent experimental data appears to be sufficiently accurate to rank order predict high affinity interactions of tandem SH2 domain recruitment to the EGFR C-terminal tail. These approaches lay the groundwork for larger utility in multivalent prediction and testing to help better understand protein interactions that drive cell signaling.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12132298 | PMC |
http://dx.doi.org/10.1101/2025.05.13.653723 | DOI Listing |
Proc Natl Acad Sci U S A
September 2025
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Noonan syndrome with multiple lentigines (NSML) is a rare autosomal dominant disorder caused by mutations in (protein tyrosine phosphatase nonreceptor type 11) which encodes for the protein tyrosine phosphatase, SHP2. Approximately 85% of NSML patients develop hypertrophic cardiomyopathy (HCM). Here, we show that SHP2 is recruited to tyrosyl phosphorylated protein-zero related (PZR) in NSML mice.
View Article and Find Full Text PDFBlood Adv
August 2025
Temple University School of Medicine, Philadelphia, Pennsylvania, United States.
Spleen tyrosine kinase (Syk) is expressed in a variety of hemopoietic cells. Its phosphorylation regulates downstream signaling events upon stimulation of receptors containing an immune tyrosine activation motif (ITAM), like glycoprotein VI (GPVI), or a hemITAM, including the C-type lectin-like receptor II-type (CLEC-2). This study focuses on the role of a specific phosphorylation site, Tyrosine 317, in the regulation of Syk function.
View Article and Find Full Text PDFbioRxiv
May 2025
Department of Biomedical Engineering and the Department for Genome Sciences, University of Virginia, Charlottesville, Virginia, United States of America.
Tandem SH2 domains occur in key protein mediators of phosphotyrosine signaling and have the capacity to drive high affinity interactions through the avidity that results with bisphosphorylated protein partners. However, challenges have prevented the broad exploration of tandem SH2 domain avidity and here we utilize advances in both computational modeling and experimental approaches to predict and test tandem SH2 domain recruitment. Theoretical model behavior suggests that maximum avidity occurs with closely spaced or flexibly linked phosphotyrosine sites, combined with moderate monovalent affinities - exactly around the affinities of SH2 domains with individual phosphotyrosine sites.
View Article and Find Full Text PDFProc Natl Acad Sci U S A
June 2025
Borch Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907.
Spleen tyrosine kinase (Syk) mediates early signaling events in immunity by coupling membrane receptors to immune responses. Syk comprises a tandem SH2 (tSH2) regulatory module-two SH2 domains connected by a structured linker-and a kinase domain. The association of tSH2 with a doubly tyrosine-phosphorylated motif (dpITAM) on membrane immunoreceptors is central to controlling Syk's signaling activity.
View Article and Find Full Text PDFSci Signal
March 2025
Faculty of Advanced Life Science, Hokkaido University, Sapporo 060-0810, Japan.
Signal transducer and activator of transcription (STAT) family members mediate signaling in the Janus kinase (JAK)-STAT pathway and are activated by phosphorylation at a conserved tyrosine residue, resulting in dimerization through reciprocal interactions between the phosphotyrosine and a Src homology 2 (SH2) domain. Tyrosine-phosphorylated STAT (pY-STAT) then translocates to the nucleus to induce the expression of genes encoding antiviral proteins. Although the active and functional forms of STATs are conventionally considered to be dimers, STATs can undergo higher-order oligomerization, which is implicated in regulating transcriptional activity.
View Article and Find Full Text PDF